CONDITION

Caffeine Toxicity

Caffeine toxicity occurs when a dog or cat consumes enough caffeine to overstimulate the nervous system and heart. Sources may include coffee (brewed or grounds), tea, energy drinks, caffeine tablets, or certain foods and medications containing caffeine. Dogs and cats are more sensitive to caffeine's effects than humans, though they eliminate caffeine at a similar rate; clinical signs can develop within one to two hours of ingestion. Owners often arrive on this page after their pet has accessed coffee, an energy drink, or caffeine-containing products, and may notice restlessness, panting, vomiting, a rapid heart rate, tremors, or agitation. The severity depends on the amount consumed and the size of the animal. In some cases, caffeine is ingested alongside chocolate, which contains both caffeine and theobromine (a related compound with a longer half-life in dogs). This page explores the signs that can appear after caffeine ingestion, the mechanisms by which caffeine affects the body, how veterinary professionals assess the exposure and clinical state, and the approaches used to manage toxicity. There is no specific antidote; supportive measures aim to limit absorption, support organ function, and manage symptoms until caffeine is cleared from the body.

Why this matters now

Caffeine toxicity can occur at any age and in any breed, arising from accidental ingestion rather than from inherent susceptibility. Episodes often follow household events such as spilled coffee, discarded energy drink cans, or access to visitors' bags containing caffeine tablets or caffeinated gum. Smaller dogs and cats are at higher risk of clinically significant toxicity from a given absolute dose, as the concentration of caffeine in the bloodstream depends on body weight. Homes with multiple caffeine sources or with products left within reach tend to see a higher incidence.

Signs typically begin within one to two hours of ingestion and may intensify over the following few hours as caffeine is absorbed from the gastrointestinal tract. The peak effect often occurs between two and four hours post-ingestion, after which signs may plateau or begin to resolve as the liver metabolises caffeine and the kidneys excrete it. In cases involving large ingestions, signs can persist for twelve to twenty-four hours or longer, reflecting caffeine's half-life in dogs and cats. The course varies with the dose consumed, the presence of food in the stomach, and individual differences in metabolism.

Signals & patterns

Early signals

Restlessness and pacing

The animal may appear unable to settle, moving from room to room or changing position frequently. This reflects the stimulant effect of caffeine on the central nervous system and can develop within the first hour or two after ingestion.

Vomiting

Vomiting may occur shortly after ingestion, particularly if a substantial volume of liquid or irritating material has been consumed. It can serve to expel some of the caffeine before absorption, though this is unpredictable.

Panting and increased thirst

Rapid, shallow breathing and frequent drinking may appear as the metabolic rate rises and the body attempts to dissipate heat. These signs often coincide with restlessness.

Elevated heart rate

The pulse may feel noticeably faster than usual when palpated at the femoral artery. Owners may also observe a visible quickening of the chest wall or hear the heart beating more forcefully.

Hyperactivity or agitation

The animal may exhibit exaggerated responses to stimuli, such as startling easily or reacting intensely to sounds or movement. This heightened arousal reflects caffeine's effect on neurotransmitter systems.

Later signals

Muscle tremors or twitching

Fine or coarse tremors may appear in the limbs, face, or trunk, often becoming more pronounced as the dose and time progress. These involuntary movements arise from overstimulation of motor pathways in the nervous system.

Abnormal heart rhythms

The heart rate may become irregular or excessively rapid, sometimes palpable as a fluttering or skipping sensation. This can reflect arrhythmias triggered by caffeine's effects on cardiac muscle and conduction.

Collapse or seizures

In severe cases, the animal may lose the ability to stand, experience generalised seizures, or show signs of profound neurological disturbance. These patterns indicate a high level of central nervous system excitation and carry a higher risk of complications.

Click to read about the biological mechanisms

How this is usually investigated

The diagnosis of caffeine toxicity rests primarily on history and clinical observation rather than specific laboratory confirmation. Owners can often describe what was consumed, how much, and when, which allows the veterinary team to estimate the dose and predict the likely course. Physical examination findings such as tachycardia, tremors, agitation, and hyperthermia support the suspicion. Targeted tests may be performed to assess the animal's metabolic state and to rule out complications, but there is no widely available bedside test to measure caffeine concentration in blood.

Physical examination

Purpose: The examination documents heart rate, respiratory rate, body temperature, mucous membrane colour, capillary refill time, neurological state, and the presence of tremors or seizures. These findings help establish the severity of toxicity and guide decisions about supportive care.
Considerations: Findings reflect the degree of sympathetic stimulation and central nervous system excitation at the time of assessment, but signs can evolve rapidly over the first few hours. The examination cannot distinguish caffeine toxicity from other methylxanthine exposures or from certain other causes of hyperactivity and tachycardia.

Chemistry panel

Purpose: Measurement of electrolytes, kidney function markers, and liver enzymes can reveal metabolic disturbances such as hypokalaemia, hyperglycaemia, or acidosis that may accompany severe toxicity. The panel also establishes baseline organ function before supportive treatments are initiated.
Considerations: The chemistry panel does not confirm caffeine exposure, and many animals with mild to moderate toxicity will have normal results. It is most informative in cases where vomiting, diarrhoea, or prolonged hyperactivity may have caused electrolyte shifts or dehydration.

Complete blood count

Purpose: The count can reveal stress-related changes such as neutrophilia or eosinopenia, though these are nonspecific. It also provides a baseline if the animal requires sedation or anticonvulsant therapy that may affect blood cell populations.
Considerations: The complete blood count rarely changes the immediate management of caffeine toxicity, as the primary decisions are driven by clinical signs rather than haematology. It may be deferred in uncomplicated cases or included as part of a broader assessment when the exposure history is uncertain.

Electrocardiography

Purpose: Continuous monitoring or a snapshot electrocardiogram documents heart rate and rhythm, identifying tachycardia, premature ventricular contractions, or other arrhythmias that can arise from caffeine's effects on cardiac conduction. The tracing helps guide the timing and choice of antiarrhythmic therapy if needed.
Considerations: Electrocardiography requires the animal to remain still enough for lead attachment, which can be difficult in an agitated or tremoring patient. Some arrhythmias resolve spontaneously as caffeine is metabolised, and not every tachycardia requires pharmacological intervention.

Blood pressure measurement

Purpose: Measurement of systemic arterial pressure can detect hypertension resulting from catecholamine release and increased cardiac output. Persistent hypertension may influence decisions about fluid therapy and the use of certain sedatives.
Considerations: Accurate blood pressure measurement requires a calm environment and appropriate cuff size, both of which can be challenging in an excited or tremoring animal. Readings may fluctuate with the animal's level of agitation, and a single elevated value does not always necessitate treatment.

Options & trade-offs

Management of caffeine toxicity is supportive, combining measures to limit further absorption, reduce circulating caffeine levels, control clinical signs, and maintain organ function until the compound is eliminated. The approach taken depends on the time since ingestion, the severity of signs, and the animal's response to initial interventions. Different combinations of decontamination, symptomatic control, and monitoring suit different clinical pictures, and the intensity of care can be adjusted as the animal's condition evolves.

Decontamination and activated charcoal

When an animal presents within one to two hours of caffeine ingestion and before significant vomiting has occurred, inducing emesis can remove unabsorbed caffeine from the stomach. Activated charcoal may be administered after vomiting or in place of it if emesis is contraindicated; the charcoal binds caffeine in the gastrointestinal tract and reduces absorption. Multiple doses of activated charcoal can interrupt enterohepatic recirculation of caffeine and its metabolites, potentially shortening the duration of toxicity.

Trade-offs: Emesis carries a risk of aspiration if the animal is already tremoring, ataxic, or sedated, and it is ineffective if caffeine has already been absorbed. Activated charcoal can cause constipation or vomiting, and some animals resist oral administration; it is also less useful if several hours have passed since ingestion and most caffeine is already systemically distributed.

Intravenous fluid therapy

Intravenous fluids support blood pressure, maintain hydration, and promote renal excretion of caffeine and its metabolites through diuresis. The rate and composition of fluids can be adjusted to correct electrolyte imbalances such as hypokalaemia, which may develop with prolonged vomiting or increased urinary losses. Fluid therapy also helps manage hyperthermia by supporting heat dissipation.

Trade-offs: Intravenous catheter placement requires venous access, which can be difficult in a hyperactive or tremoring patient, and the catheter must be secured to prevent dislodgement. Excessive fluid administration can lead to volume overload, particularly in animals with underlying heart disease or if cardiac arrhythmias are present.

Sedation and anticonvulsant therapy

Benzodiazepines such as diazepam or midazolam can reduce agitation, control tremors, and raise the seizure threshold, making the animal safer to handle and lowering the metabolic demand created by continuous muscle activity. If seizures occur, anticonvulsants are administered to terminate the event and prevent recurrence. Light sedation also facilitates other treatments such as catheter placement and monitoring.

Trade-offs: Sedatives can depress respiration or lower blood pressure, requiring close monitoring and sometimes supplemental oxygen or adjustment of fluid rates. The degree of sedation needed varies widely between individuals, and some animals may require repeated doses or continuous infusion if signs are severe or prolonged.

Antiarrhythmic and heart-rate control

Beta-blockers such as propranolol or atenolol can slow the heart rate and reduce the force of cardiac contractions when tachycardia is marked or sustained. Antiarrhythmic drugs may be used if electrocardiography reveals ventricular arrhythmias that pose a risk of decompensation. Controlling heart rate can also lower myocardial oxygen demand and reduce the risk of ischaemic injury.

Trade-offs: Beta-blockers can cause hypotension, bradycardia, or bronchospasm in susceptible animals, and they interact with other medications and underlying conditions such as asthma or heart failure. Not all tachycardias require pharmacological intervention, as many resolve as caffeine levels decline, and the decision to treat depends on the severity and persistence of the arrhythmia.

Temperature management and monitoring

Hyperthermia arising from muscle tremors, seizures, and increased metabolic rate can be managed with external cooling such as fans, cool but not iced water, or wet towels, combined with sedation to reduce heat production. Continuous monitoring of rectal temperature prevents overcooling. In cases of mild toxicity, observation without intensive intervention may be appropriate if the animal remains stable and signs are resolving.

Trade-offs: Aggressive cooling can cause hypothermia, shivering, and peripheral vasoconstriction, which can worsen cardiovascular instability. Monitoring requires repeated handling, which can increase stress and agitation in an already hyperexcitable animal; balancing the frequency of checks with the animal's tolerance is part of individualising care.

Common misconceptions

Misconception:

"A small amount of coffee or tea cannot harm a dog or cat."

Reality:

The toxicity of caffeine depends on the dose consumed relative to the animal's body weight, and small dogs and cats can develop clinical signs from amounts that seem trivial to a human. Brewed coffee contains approximately 95 milligrams of caffeine per cup, and espresso or energy drinks can contain significantly more; even a few laps or a small spillage can be clinically relevant in a toy-breed dog or cat. Coffee grounds, caffeine tablets, and certain caffeinated foods are particularly concentrated sources.

Misconception:

"If the animal has vomited, the caffeine is no longer a concern."

Reality:

Vomiting may expel some unabsorbed caffeine, but significant absorption can occur within thirty to sixty minutes of ingestion, and caffeine that has entered the bloodstream will not be removed by emesis. Clinical signs can continue to develop or intensify even after the stomach has been emptied, reflecting the ongoing distribution and effects of caffeine already circulating. Supportive care remains important until signs resolve and caffeine is cleared by the liver and kidneys.

Misconception:

"Caffeine toxicity resolves quickly once the animal stops tremoring."

Reality:

Tremors are one visible sign of caffeine's effects on the central nervous system, but other disturbances such as tachycardia, hypertension, and arrhythmias may persist after tremors subside. The half-life of caffeine in dogs and cats means that it can take many hours for the compound to be fully eliminated, and some animals remain at risk of complications such as seizures or cardiac events during this clearance period. Monitoring and supportive care often continue well beyond the resolution of the most obvious signs.

Related conditions

Chocolate Toxicity in Dogs

Chocolate contains both caffeine and theobromine, a related methylxanthine compound. When a dog ingests chocolate, both substances contribute to toxicity, though theobromine typically dominates the clinical picture due to its longer half-life in dogs—approximately 17.5 hours compared to caffeine's 4.5 hours—and its higher concentration in most chocolate products.

Cannabis Toxicity

Cannabis toxicity can produce some overlapping signs with caffeine toxicity, including agitation, tremors, and altered mentation, though the overall pattern tends to differ. Where caffeine typically causes hyperactivity and tachycardia, cannabis more often produces ataxia, urinary incontinence, and a characteristic glazed expression, making the distinction important when the ingestion history is unclear.

Acute Kidney Injury

Severe caffeine toxicity can lead to sustained tachycardia, hypertension, and in some cases hyperthermia or seizures, all of which may reduce blood flow to the kidneys. In rare instances, particularly when treatment is delayed or the dose is very high, this can contribute to acute kidney injury, though this represents an uncommon complication rather than a typical feature.

Anticoagulant Rodenticide Toxicity

Both caffeine toxicity and anticoagulant rodenticide toxicity can occur when a dog gains access to household products not intended for consumption. The clinical presentations differ markedly—caffeine affects the nervous system and heart within hours, while rodenticide toxicity causes bleeding that may not become apparent for days—but both illustrate the range of hazards present in typical home environments.

Epilepsy in Dogs

Caffeine toxicity can trigger seizures in dogs, particularly at higher doses, through overstimulation of the central nervous system. These seizures are typically part of an acute toxic syndrome rather than a recurring pattern, but the episode may prompt investigation to distinguish toxin-induced seizure activity from idiopathic epilepsy, especially if the ingestion was not witnessed.

After an episode of caffeine toxicity has been managed, attention often turns to identifying how the exposure occurred and what changes in the household might reduce the likelihood of recurrence. Many ingestions happen when bags, travel mugs, or discarded containers are left within reach, or when visitors bring caffeinated products that the animal finds. Understanding the range of caffeine-containing items in the home and the animal's patterns of scavenging or curiosity can be a useful conversation to have as part of follow-up care.

Last reviewed: 12 September 2026 · Dr Alastair Greenway MRCVS